Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Cady

Showing results (41-50 of 98) with videos related to

Pageof 10
Sort By:
Clinical Therapeutics|March 15, 2003
An open-label study to assess changes in efficacy and satisfaction with migraine care when patients have access to multiple sumatriptan succinate formulationsEric Weidmann, Jeffrey Unger, Stephen Blair, et al.
Pain Management|December 12, 2024
Headache-related stigma and quality of life in adults with frequent headaches/migraine and frequent medication use: a plain language summaryDawn C Buse, Roger Cady, Amaal J Starling, et al.
Headache|September 28, 2004
Migraine treatment with rizatriptan and non-triptan usual care medications: a pharmacy-based studyRoger Cady, Vincent Martin, James Adelman, et al.
Headache|April 28, 2004
Inpatient treatment of headache: an evidence-based assessmentFrederick G Freitag, Al Lake, Richard Lipton, et al.
Headache|November 9, 2020
Eptinezumab Demonstrated Efficacy in Sustained Prevention of Episodic and Chronic Migraine Beginning on Day 1 After DosingDavid W Dodick, Christopher Gottschalk, Roger Cady, et al.
The Journal of Headache and Pain|February 8, 2022
Patient-reported outcomes, health-related quality of life, and acute medication use in patients with a ≥ 75% response to eptinezumab: subgroup pooled analysis of the PROMISE trialsRichard B Lipton, Larry Charleston, Cristina Tassorelli, et al.
BMC Medical Informatics and Decision Making|July 14, 2023
Using artificial intelligence to identify patients with migraine and associated symptoms and conditions within electronic health recordsDaniel Riskin, Roger Cady, Anand Shroff, et al.
Headache|October 24, 2013
An exploratory study of salivary calcitonin gene-related peptide levels relative to acute interventions and preventative treatment with onabotulinumtoxinA in chronic migraineRoger Cady, Ira Turner, Kent Dexter, et al.
Headache|June 26, 2024
Long-term effectiveness of eptinezumab in the treatment of patients with chronic migraine and medication-overuse headacheAndrew Blumenfeld, David Kudrow, Peter McAllister, et al.
The Journal of Headache and Pain|February 22, 2022
Early response to eptinezumab indicates high likelihood of continued response in patients with chronic migraineDawn C Buse, Paul K Winner, Larry Charleston, et al.
Pageof 10

Showing results (41-50 of 98) with videos related to

Sort By:
Pageof 10
Clinical Therapeutics|March 15, 2003
An open-label study to assess changes in efficacy and satisfaction with migraine care when patients have access to multiple sumatriptan succinate formulationsEric Weidmann, Jeffrey Unger, Stephen Blair, et al.
Pain Management|December 12, 2024
Headache-related stigma and quality of life in adults with frequent headaches/migraine and frequent medication use: a plain language summaryDawn C Buse, Roger Cady, Amaal J Starling, et al.
Headache|September 28, 2004
Migraine treatment with rizatriptan and non-triptan usual care medications: a pharmacy-based studyRoger Cady, Vincent Martin, James Adelman, et al.
Headache|April 28, 2004
Inpatient treatment of headache: an evidence-based assessmentFrederick G Freitag, Al Lake, Richard Lipton, et al.
Headache|November 9, 2020
Eptinezumab Demonstrated Efficacy in Sustained Prevention of Episodic and Chronic Migraine Beginning on Day 1 After DosingDavid W Dodick, Christopher Gottschalk, Roger Cady, et al.
The Journal of Headache and Pain|February 8, 2022
Patient-reported outcomes, health-related quality of life, and acute medication use in patients with a ≥ 75% response to eptinezumab: subgroup pooled analysis of the PROMISE trialsRichard B Lipton, Larry Charleston, Cristina Tassorelli, et al.
BMC Medical Informatics and Decision Making|July 14, 2023
Using artificial intelligence to identify patients with migraine and associated symptoms and conditions within electronic health recordsDaniel Riskin, Roger Cady, Anand Shroff, et al.
Headache|October 24, 2013
An exploratory study of salivary calcitonin gene-related peptide levels relative to acute interventions and preventative treatment with onabotulinumtoxinA in chronic migraineRoger Cady, Ira Turner, Kent Dexter, et al.
Headache|June 26, 2024
Long-term effectiveness of eptinezumab in the treatment of patients with chronic migraine and medication-overuse headacheAndrew Blumenfeld, David Kudrow, Peter McAllister, et al.
The Journal of Headache and Pain|February 22, 2022
Early response to eptinezumab indicates high likelihood of continued response in patients with chronic migraineDawn C Buse, Paul K Winner, Larry Charleston, et al.
Pageof 10